Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions.

E. A. Lindsay, R. Goldberg, V. Jurecic, Bernice E. Morrow, C. Carlson, R. S. Kucherlapati, R. J. Shprintzen, A. Baldini

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Velo-cardio-facial (VCFS) or Shprintzen syndrome is associated with deletions in a region of chromosome 22q11.2 also deleted in DiGeorge anomaly and some forms of congenital heart disease. Due to the variability of phenotype, the evaluation of the incidence of deletions has been hampered by uncertainty of diagnosis. In this study, 54 patients were diagnosed with VCFS by a single group of clinicians using homogeneous clinical criteria independent of the deletion status. Cell lines of these patients were established and the deletion status evaluated for three loci within the commonly deleted region at 22q11.2 using fluorescence in situ hybridization (FISH). In 81% of the patients all three loci were hemizygous. In one patient we observed a smaller interstitial deletion than that defined by the three loci. The phenotype of this patient was not different from that observed in patients with larger deletions.

Original languageEnglish (US)
Pages (from-to)514-522
Number of pages9
JournalAmerican Journal of Medical Genetics - Seminars in Medical Genetics
Volume57
Issue number3
StatePublished - Jul 3 1995
Externally publishedYes

Fingerprint

DiGeorge Syndrome
Phenotype
Fluorescence In Situ Hybridization
Uncertainty
Heart Diseases
Chromosomes
Cell Line
Incidence

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Lindsay, E. A., Goldberg, R., Jurecic, V., Morrow, B. E., Carlson, C., Kucherlapati, R. S., ... Baldini, A. (1995). Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. American Journal of Medical Genetics - Seminars in Medical Genetics, 57(3), 514-522.

Velo-cardio-facial syndrome : frequency and extent of 22q11 deletions. / Lindsay, E. A.; Goldberg, R.; Jurecic, V.; Morrow, Bernice E.; Carlson, C.; Kucherlapati, R. S.; Shprintzen, R. J.; Baldini, A.

In: American Journal of Medical Genetics - Seminars in Medical Genetics, Vol. 57, No. 3, 03.07.1995, p. 514-522.

Research output: Contribution to journalArticle

Lindsay, EA, Goldberg, R, Jurecic, V, Morrow, BE, Carlson, C, Kucherlapati, RS, Shprintzen, RJ & Baldini, A 1995, 'Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions.', American Journal of Medical Genetics - Seminars in Medical Genetics, vol. 57, no. 3, pp. 514-522.
Lindsay, E. A. ; Goldberg, R. ; Jurecic, V. ; Morrow, Bernice E. ; Carlson, C. ; Kucherlapati, R. S. ; Shprintzen, R. J. ; Baldini, A. / Velo-cardio-facial syndrome : frequency and extent of 22q11 deletions. In: American Journal of Medical Genetics - Seminars in Medical Genetics. 1995 ; Vol. 57, No. 3. pp. 514-522.
@article{19edf6ac8010465f9f8ff920c8d08ba5,
title = "Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions.",
abstract = "Velo-cardio-facial (VCFS) or Shprintzen syndrome is associated with deletions in a region of chromosome 22q11.2 also deleted in DiGeorge anomaly and some forms of congenital heart disease. Due to the variability of phenotype, the evaluation of the incidence of deletions has been hampered by uncertainty of diagnosis. In this study, 54 patients were diagnosed with VCFS by a single group of clinicians using homogeneous clinical criteria independent of the deletion status. Cell lines of these patients were established and the deletion status evaluated for three loci within the commonly deleted region at 22q11.2 using fluorescence in situ hybridization (FISH). In 81{\%} of the patients all three loci were hemizygous. In one patient we observed a smaller interstitial deletion than that defined by the three loci. The phenotype of this patient was not different from that observed in patients with larger deletions.",
author = "Lindsay, {E. A.} and R. Goldberg and V. Jurecic and Morrow, {Bernice E.} and C. Carlson and Kucherlapati, {R. S.} and Shprintzen, {R. J.} and A. Baldini",
year = "1995",
month = "7",
day = "3",
language = "English (US)",
volume = "57",
pages = "514--522",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Velo-cardio-facial syndrome

T2 - frequency and extent of 22q11 deletions.

AU - Lindsay, E. A.

AU - Goldberg, R.

AU - Jurecic, V.

AU - Morrow, Bernice E.

AU - Carlson, C.

AU - Kucherlapati, R. S.

AU - Shprintzen, R. J.

AU - Baldini, A.

PY - 1995/7/3

Y1 - 1995/7/3

N2 - Velo-cardio-facial (VCFS) or Shprintzen syndrome is associated with deletions in a region of chromosome 22q11.2 also deleted in DiGeorge anomaly and some forms of congenital heart disease. Due to the variability of phenotype, the evaluation of the incidence of deletions has been hampered by uncertainty of diagnosis. In this study, 54 patients were diagnosed with VCFS by a single group of clinicians using homogeneous clinical criteria independent of the deletion status. Cell lines of these patients were established and the deletion status evaluated for three loci within the commonly deleted region at 22q11.2 using fluorescence in situ hybridization (FISH). In 81% of the patients all three loci were hemizygous. In one patient we observed a smaller interstitial deletion than that defined by the three loci. The phenotype of this patient was not different from that observed in patients with larger deletions.

AB - Velo-cardio-facial (VCFS) or Shprintzen syndrome is associated with deletions in a region of chromosome 22q11.2 also deleted in DiGeorge anomaly and some forms of congenital heart disease. Due to the variability of phenotype, the evaluation of the incidence of deletions has been hampered by uncertainty of diagnosis. In this study, 54 patients were diagnosed with VCFS by a single group of clinicians using homogeneous clinical criteria independent of the deletion status. Cell lines of these patients were established and the deletion status evaluated for three loci within the commonly deleted region at 22q11.2 using fluorescence in situ hybridization (FISH). In 81% of the patients all three loci were hemizygous. In one patient we observed a smaller interstitial deletion than that defined by the three loci. The phenotype of this patient was not different from that observed in patients with larger deletions.

UR - http://www.scopus.com/inward/record.url?scp=0029634412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029634412&partnerID=8YFLogxK

M3 - Article

C2 - 7677167

AN - SCOPUS:0029634412

VL - 57

SP - 514

EP - 522

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -